Wen-zhao F. Zhong
106 Zhongshan 2nd Rd
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 240 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.
Journal: Annals of surgical oncology
Published: August 11, 2026
ASO Visual Abstract: Pathologic Response, Tumor Microenvironment Dynamics, and Survival Dissociation After Neoadjuvant Chemoimmunotherapy for Lung Cancer With Rare Histologic Subtypes.
Journal: Annals of surgical oncology
Published: July 31, 2026
Soft tissue augmentation for phenotype modification prior to orthodontics treatment in a class Ⅲ malocclusion patient with gingival recession: a 5-year follow-up case report
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: July 30, 2026
Identification and validation of plasma biomarkers for mild cognitive impairment based on mRNA N6-methyladenosine methylome analysis
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: June 29, 2026
Circulating tumor DNA analysis in lung cancer: from molecular origins to analytical boundaries.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 12, 2026
Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 11, 2026
Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.
Journal: Annals of surgical oncology
Published: March 12, 2026
Survival outcomes and molecular predictors in small cell lung cancer with brain metastases receiving immunotherapy.
Journal: Journal of neuro-oncology
Published: March 03, 2026
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 26, 2026
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China.
Journal: EClinicalMedicine
Published: January 25, 2026
Adjuvant immunotherapy may have no impact on survival in patients who received neoadjuvant immunotherapy for stage II-IIIB non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 18, 2026
Last Updated: 09/26/2026